Hepatitis Foundation International   photo
The Good We Do Living with Hepatitis News and Research Support Education Donate Contact Us Home

 

Heplink Online Learning Center Subscribe to Our Newsletter E-Store

Clinical Trials Resource Center

About Research  |   Trials  |   NIH Trials  |   Email Notifications  |   FDA Approvals  |   Research Centers
Research Headlines  |   NMT Results  |   Bookstore

Therapeutic Areas: Cardiology/Vascular Diseases

Atrial Flutter Clinical Trials

A listing of Atrial Flutter medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alaska

UPDATED

Anchorage Alaska 99508

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Arizona

UPDATED

Phoenix Arizona 85004

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

California

UPDATED

Pasadena California 91105

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Sacramento California 95816

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Colorado

UPDATED

Aurora Colorado 80045

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Denver Colorado 80120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Florida

University of South Florida - South Tampa Center for Advanced Healthcare
Tampa Florida 33606

GENETIC-AF: A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure

UPDATED

Miami Florida 33136

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Tampa Florida 33606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Georgia

UPDATED

Athens Georgia 30606

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Catheter ablation for patients with Atrial Flutter or Arrhythmia

Illinois

UPDATED

Gurnee Illinois 60031

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Oakbrook Terrace Illinois 60181

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Indiana

UPDATED

Hammond Indiana 46320

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Indianapolis Indiana 46260

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Michigan

UPDATED

Royal Oak Michigan 48703

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Ypsilanti Michigan 48197

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Minnesota

UPDATED

Minneapolis Minnesota 55417

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

St. Paul Minnesota 55102

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Missouri

UPDATED

St. Louis Missouri 63110

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nebraska

UPDATED

Lincoln Nebraska 68506

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Omaha Nebraska 68198

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New Jersey

UPDATED

Elmer New Jersey 08318

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

New York

UPDATED

Albany New York 12205

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

North Carolina

UPDATED

Durham North Carolina 27705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Greensboro North Carolina 27401

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Ohio

UPDATED

Akron Ohio 44304

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Cleveland Ohio 44106

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Columbus Ohio 43210

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oklahoma

UPDATED

Oklahoma City Oklahoma 73120

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Oregon

UPDATED

Portland Oregon 97201

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Pennsylvania

UPDATED

Hershey Pennsylvania 17033

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Lancaster Pennsylvania 17603

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Pittsburgh Pennsylvania 15212

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Tennessee

UPDATED

Jackson Tennessee 38305

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Nashville Tennessee 37232

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Nashville Tennessee 37232

A clinical research study of dabigatran etexilate mesylate for the treatment of Atrial Fibrillation or Atrial Flutter

Texas

UPDATED

Austin Texas 78705

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Virginia

UPDATED

Norfolk Virginia 23507

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Washington

UPDATED

Puyallup Washington 98372

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

Canada

UPDATED

Calgary Alberta T2N 4Z6

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Cambridge Ontario N1R 6V6

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Cambridge Ontario N1R 7R1

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Hamilton Ontario L8L 2X2

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

London Ontario N6A 5A5

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Montreal Quebec H2W 1T8

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Montreal Quebec H1T 1C8

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Montreal Quebec H3G 1A3

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Newmarket Ontario L3Y 2P6

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

UPDATED

Oshawa Ontario L1H 1B9

A Phase 2/Phase 3 clinical study for patients with Atrial Fibrillation or Atrial Flutter

the good we do  |  living with hepatitis  |  news & research  |  support donate  |  contact us  |  site map  |   home

nnac  |  online learning center  |  subscribe to our newsletter   |   disclaimer  |  privacy

 

 

Hepatitis Foundation International
(800) 891-0707
HFI@comcast.net

©2003. All rights reserved.